Back to top

Sino Biopharmaceutical (SBMFF) Receives a Buy from UBS

In a report released on July 24, from UBS maintained a Buy rating on Sino Biopharmaceutical, with a price target of HK$7.70. The company’s shares c...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Sino Biopharmaceutical (SBMFF)